Clinical Trials

New Search
Title   Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)
Disease/Condition   Breast Cancer
Eligibility Criteria   Ages Eligible for Study: 18 Years to 42 Years (Adult) Genders Eligible for Study: Female Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal¬†Investigator   Joseph Sparano, MD
Contact¬†Name   Karen Fehn
Phone   (718) 405-8446
Contact Email
IRB/Protocol¬†Number   IRB# A221405
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No